$450,000 39.3%
Total revenue, Q2 '25 (USD).

Did DURECT Beat Earnings?

DURECT (DRRX) reported Q2 '25 revenue of $450,000, down 79.4% year-over-year.

AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — DURECT’s job postings, web traffic, and employee business outlook. See the full DRRX stock analysis or the earnings calendar for upcoming reports.

DURECT Quarterly Financial Trends (USD)

MetricQ3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25
Revenue1.7M2.7M1.8M2.2M1.9M450,000320,000450,000
Gross margin82.1%75.3%84.2%83.6%73.4%95.1%78.5%98.4%
Operating margin-548.0%-234.3%-312.9%-156.8%-205.9%-1,285.7%-1,289.4%-627.1%
Net income-3M-1.4M-7.6M-3.7M-4.3M7.3M-4.2M-2.3M
Net margin-172.9%-54.0%-418.3%-170.4%-222.4%1,612.4%-1,318.4%-506.7%
EPS

DURECT Earnings Trend Analysis

Over the eight quarters from Q3 '23 to Q2 '25, DURECT’s quarterly revenue moved from $1.7M to $450,000. Net margin compressed from -172.9% to -506.7%, against a 98.4% gross margin in the most recent quarter — a read on whether revenue growth is translating into profit.

When Is DURECT’s Next Earnings Date?

DURECT reports earnings on a quarterly schedule. Its most recent report covered Q2 '25. For the confirmed upcoming date — and every other company reporting soon — see the DRRX earnings calendar.

Frequently Asked Questions: DURECT Earnings

DURECT's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.

DURECT reported Q2 '25 revenue of $450,000, down 79.4% from the same quarter a year earlier.

Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the DRRX AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.